Related Experiment Video
Updated: Nov 1, 2025

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
Down-regulation of a panel of immune-related lncRNAs in breast cancer
Soudeh Ghafouri-Fard1, Mohammad Asadi2, Behnoush Sohrabi3
1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
Breast cancer is a common neoplasm among women. This type of cancer is among malignancies in which role of long non-coding RNAs (lncRNAs) has been extensively explored. Some recently recognized lncRNAs have been less investigated in this neoplastic condition. LncRNAs that regulate tumor immunity are among those contributing in the pathogenesis of cancer. In the present expression assay, we compared expressions of nine immune-related lncRNAs namely lnc-MICAL3-2 (AC016027.1), lnc-DDX31 (AL445645.1), LINC01063, LINC02381, ENST0000615051 (AC083809.1), AC009237.14 (lnc-TRIM43B-1), ENST0000603791, LINC1234 and AC008760.1 between breast cancer samples and their paired non-cancerous samples. Expression levels of lnc-MICAL3-2, lnc-DDX31, LINC01063, LINC02381, ENST0000615051 and lnc-TRIM43B-1 were significantly decreased in breast cancer samples compared with paired control tissues (Posterior mean difference= -2.774, -2.012, -2.012, -2.015, -0.884 and -2.872; P values= 0.019, 0.0001, 0.0001, 0.0001, 0.032 and 0.0001, respectively). Expression levels of these lncRNAs have been associated with a number of clinical characteristics of breast cancer patients. Lnc-TRIM43B-1 had the highest performance in distinguishing between tumoral and non-tumoral tissues (AUC=0.82, Sensitivity=76%, Specificity=73.24%). As these lncRNAs could differentiate tumor samples from control samples, they might be regarded as putative tissue markers for breast cancer.
Insights
This study investigated nine immune-related long non-coding RNAs (lncRNAs) in breast cancer. Six lncRNAs were found to be downregulated in tumor tissues, suggesting their potential as novel biomarkers for breast cancer detection.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a prevalent malignancy in women, with long non-coding RNAs (lncRNAs) playing an increasingly recognized role in its pathogenesis.
- Immune-related lncRNAs are crucial in cancer development, but some remain under-investigated in breast cancer.
- Understanding the expression patterns of specific lncRNAs can offer insights into tumor immunity and progression.
Purpose of the Study:
- To compare the expression levels of nine selected immune-related lncRNAs between breast cancer tissues and paired non-cancerous tissues.
- To evaluate the potential of these lncRNAs as diagnostic biomarkers for breast cancer.
- To explore the association between the expression of these lncRNAs and clinical characteristics of breast cancer patients.
Main Methods:
- Gene expression analysis was performed on paired breast cancer and adjacent non-cancerous tissue samples.
- Quantitative real-time PCR or similar expression assay was used to measure the levels of nine specific immune-related lncRNAs.
- Statistical analyses, including differential expression analysis and receiver operating characteristic (ROC) curve analysis, were conducted to assess significance and diagnostic performance.
Main Results:
- Six of the nine investigated lncRNAs (lnc-MICAL3-2, lnc-DDX31, LINC01063, LINC02381, ENST0000615051, and lnc-TRIM43B-1) showed significantly decreased expression in breast cancer samples compared to control tissues.
- The expression levels of these downregulated lncRNAs were found to correlate with various clinical features of breast cancer.
- Lnc-TRIM43B-1 demonstrated high accuracy in differentiating between tumor and non-tumor tissues, with an AUC of 0.82, sensitivity of 76%, and specificity of 73.24%.
Conclusions:
- The identified downregulated immune-related lncRNAs may serve as potential tissue biomarkers for breast cancer diagnosis.
- These lncRNAs' ability to distinguish between tumoral and non-tumoral tissues highlights their clinical relevance.
- Further research into the functional roles of these lncRNAs in breast cancer immunity and progression is warranted.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Nucleolus
